Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking
NCT03847545Completed
- Sponsor
- University of Southern Denmark
- Start
- Dec 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dalfampridine in multiple sclerosis (MS), sponsored by University of Southern Denmark. Primary endpoint: Gait Profile Score at 14 days. Started Dec 2018; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03847545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03847545.